Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01531608 · ClinicalTrials.gov registry record
Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 20
- Enrollment target
NCT01531608: Completed study, sponsored by University of Virginia.
NCT01531608 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01531608 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a single-institution study seeking to evaluate if mobile gamma camera imaging can be used independent of standard fixed gamma camera imaging in patients undergoing sentinel node biopsy for melanoma.
Primary Outcome
A "miss" is any alteration in surgical plan after review of FGC data to prevent decr sensitivity for the sentinel node (SN), or incr morbidity. Any change to surgical plan that results in a change of anatomic or incision location, or addition of lymph node (LN) location will qualify as a miss. Removal of "hot" LN based on MGC data that would not have been removed based on FGC imaging will not be counted as a "miss," incl non-localization of a SN by FGC imaging, provided they are within 10% of th
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-02 |
What the finished NCT01531608 record still lists
NCT01531608 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01531608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01531608 about?
NCT01531608 is a clinical study titled "Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma". This is a single-institution study seeking to evaluate if mobile gamma camera imaging can be used independent of standard fixed gamma camera imaging in patients undergoing sentinel node biopsy for melanoma.
What is the current status of trial NCT01531608?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-03. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01531608?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia